Evidence map›Paper›PMID 37620585›Full record

ArticleNature structural & molecular biology2023

Lis1 relieves cytoplasmic dynein-1 autoinhibition by acting as a molecular wedge.

Eva P Karasmanis, Janice M Reimer, Agnieszka A Kendrick, Kendrick H V Nguyen, Jennifer A Rodriguez, Joey B Truong, Indrajit Lahiri, Samara L Reck-Peterson, Andres E Leschziner

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Multiple steps of dynein activation by Lis1 visualized by cryo-EM.Nature structural & molecular biology · 2025
    Article
  11. Article
  12. Nde1 Promotes Lis1 Binding to Full-Length Autoinhibited Human Dynein-1.bioRxiv : the preprint server for biology · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. VezA/vezatin facilitates proper assembly of the dynactin complex in vivo.bioRxiv : the preprint server for biology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Nde1 Promotes Lis1-Mediated Activation of Dynein.bioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Eva P Karasmanis *Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0139-0210
Janice M Reimer *Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Agnieszka A Kendrick *Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3254-4582
Kendrick H V NguyenDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Jennifer A RodriguezDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Joey B TruongDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0009-0008-7438-1615
Indrajit LahiriSchool of Biosciences, University of Sheffield, Sheffield, UK.
Samara L Reck-PetersonDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. sreckpeterson@ucsd.edu.ORCID http://orcid.org/0000-0002-1553-465X
Andres E LeschzinerDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. aleschziner@ucsd.edu.ORCID http://orcid.org/0000-0002-7732-7023
University of California San Diego · USHoward Hughes Medical Institute · USUniversity of Sheffield · GB

Funding

Mechanism of cytoskeletal transport and transcription-coupled DNA repairR35GM145296 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Andres E Leschziner · 2022 to 2026
$3.5M
Regulation of Cytoplasmic DyneinR01GM107214 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LESCHZINER, ANDRES · 2014 to 2021
$3.1M
Mechanisms of microtubule-based transportR35GM141825 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI RECK-PETERSON, SAMARA L · 2021 to 2025
$1.9M
NIGMS NIH HHS R01 GM107214NIGMS NIH HHS R35 GM141825NIGMS NIH HHS R35 GM145296
6 · The paper itself

Abstract

Cytoplasmic dynein-1 transports intracellular cargo towards microtubule minus ends. Dynein is autoinhibited and undergoes conformational changes to form an active complex that consists of one or two dynein dimers, the dynactin complex, and activating adapter(s). The Lissencephaly 1 gene, LIS1, is genetically linked to the dynein pathway from fungi to mammals and is mutated in people with the neurodevelopmental disease lissencephaly. Lis1 is required for active dynein complexes to form, but how it enables this is unclear. Here, we present a structure of two yeast dynein motor domains with two Lis1 dimers wedged in-between. The contact sites between dynein and Lis1 in this structure, termed 'Chi,' are required for Lis1's regulation of dynein in Saccharomyces cerevisiae in vivo and the formation of active human dynein-dynactin-activating adapter complexes in vitro. We propose that this structure represents an intermediate in dynein's activation pathway, revealing how Lis1 relieves dynein's autoinhibited state.

Indexed as

Classical Lissencephalies and Subcortical Band HeterotopiasCytoplasmic DyneinsAnimalsBiological TransportCytoskeletonDynactin ComplexDyneinsHumansMammalsOligonucleotidesCytoplasmic DyneinsDynactin ComplexDyneinsOligonucleotides

Identifiers

PMID37620585
PMCPMC10497415
OpenAlexW4386142517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.